{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:09:28Z","timestamp":1779275368563,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T00:00:00Z","timestamp":1676073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T00:00:00Z","timestamp":1676073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2020\/03854-4"],"award-info":[{"award-number":["2020\/03854-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["141601\/2019-1"],"award-info":[{"award-number":["141601\/2019-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["311530\/2019-2"],"award-info":[{"award-number":["311530\/2019-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Computed tomographies (CT) are useful for identifying muscle loss in non-small lung cancer (NSCLC) cachectic patients. However, we lack consensus on the best cutoff point for pectoralis muscle loss. We aimed to characterize NSCLC patients based on muscularity, clinical data, and the transcriptional profile from the tumor microenvironment to build a cachexia classification model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We used machine learning to generate a muscle loss prediction model, and the tumor's cellular and transcriptional profile was characterized in patients with low muscularity. First, we measured the pectoralis muscle area (PMA) of 211 treatment-naive NSCLC patients using CT available in The Cancer Imaging Archive. The cutoffs were established using machine learning algorithms (CART and Cutoff Finder) on PMA, clinical, and survival data. We evaluated the prediction model in a validation set (36 NSCLC). Tumor RNA-Seq (GSE103584) was used to profile the transcriptome and cellular composition based on digital cytometry.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>CART demonstrated that a lower PMA was associated with a high risk of death (HR\u2009=\u20091.99). Cutoff Finder selected PMA cutoffs separating low-muscularity (LM) patients based on the risk of death (<jats:italic>P<\/jats:italic>-value\u2009=\u20090.003; discovery set). The cutoff presented 84% of success in classifying low muscle mass. The high risk of LM patients was also found in the validation set. Tumor RNA-Seq revealed 90 upregulated secretory genes in LM that potentially interact with muscle cell receptors. The LM upregulated genes enriched inflammatory biological processes. Digital cytometry revealed that LM patients presented high proportions of cytotoxic and exhausted CD8+\u2009T cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our prediction model identified cutoffs that distinguished patients with lower PMA and survival with an inflammatory and immunosuppressive TME enriched with inflammatory factors and CD8+\u2009T cells.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-023-03901-5","type":"journal-article","created":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T05:03:14Z","timestamp":1676091794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Low muscle mass in lung cancer is associated with an inflammatory and immunosuppressive tumor microenvironment"],"prefix":"10.1186","volume":"21","author":[{"given":"Sarah Santiloni","family":"Cury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diogo","family":"de Moraes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakeline Santos","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula Paccielli","family":"Freire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia Pintor","family":"dos Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Miguel Luiz","family":"Batista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9rica Nishida","family":"Hasimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4901-7714","authenticated-orcid":false,"given":"Robson Francisco","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,11]]},"reference":[{"key":"3901_CR1","doi-asserted-by":"publisher","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","volume":"4","author":"VE Baracos","year":"2018","unstructured":"Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KCH. Cancer-associated cachexia. Nat Rev Dis Primer. 2018;4:17105.","journal-title":"Nat Rev Dis Primer"},{"key":"3901_CR2","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s00520-014-2534-3","volume":"23","author":"M Kimura","year":"2015","unstructured":"Kimura M, Naito T, Kenmotsu H, Taira T, Wakuda K, Oyakawa T, et al. Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer. Support Care Cancer. 2015;23:1699\u2013708.","journal-title":"Support Care Cancer"},{"key":"3901_CR3","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553:446\u201354.","journal-title":"Nature"},{"key":"3901_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489\u201395.","journal-title":"Lancet Oncol"},{"key":"3901_CR5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/jcsm.12268","volume":"9","author":"F Buckinx","year":"2018","unstructured":"Buckinx F, Landi F, Cesari M, Fielding RA, Visser M, Engelke K, et al. Pitfalls in the measurement of muscle mass: a need for a reference standard: measurement of muscle mass. J Cachexia Sarcopenia Muscle. 2018;9:269\u201378.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3901_CR6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/SPC.0b013e328331124a","volume":"3","author":"CM Prado","year":"2009","unstructured":"Prado CM, Birdsell LA, Baracos VE. The emerging role of computerized tomography in assessing cancer cachexia. Curr Opin Support Palliat Care. 2009;3:269\u201375.","journal-title":"Curr Opin Support Palliat Care"},{"key":"3901_CR7","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1148\/radiol.2263020036","volume":"226","author":"SJ Swensen","year":"2003","unstructured":"Swensen SJ, Jett JR, Hartman TE, Midthun DE, Sloan JA, Sykes A-M, et al. Lung Cancer Screening with CT: Mayo Clinic Experience. Radiology. 2003;226:756\u201361.","journal-title":"Radiology"},{"key":"3901_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1158\/1055-9965.EPI-15-1067","volume":"26","author":"CM Kinsey","year":"2017","unstructured":"Kinsey CM, San Jos\u00e9 Est\u00e9par R, van der Velden J, Cole BF, Christiani DC, Washko GR. Lower pectoralis muscle area is associated with a worse overall survival in non-small cell lung cancer. Cancer Epidemiol Biomarkers Prev. 2017;26:38\u201343.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3901_CR9","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.3390\/cancers11091251","volume":"11","author":"SS Cury","year":"2019","unstructured":"Cury SS, de Moraes D, Freire PP, de Oliveira G, Marques DVP, Fernandez GJ, et al. Tumor transcriptome reveals high expression of IL-8 in non-small cell lung cancer patients with low pectoralis muscle area and reduced survival. Cancers. 2019;11:1251.","journal-title":"Cancers"},{"key":"3901_CR10","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/jcsm.12565","volume":"11","author":"PP Freire","year":"2020","unstructured":"Freire PP, Fernandez GJ, Moraes D, Cury SS, Dal Pai-Silva M, Reis PP, et al. The expression landscape of cachexia-inducing factors in human cancers. J Cachexia Sarcopenia Muscle. 2020;11:947\u201361.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3901_CR11","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1177\/1534735418781743","volume":"17","author":"J S\u00f8rensen","year":"2018","unstructured":"S\u00f8rensen J. Lung Cancer Cachexia: Can Molecular Understanding Guide Clinical Management? Integr Cancer Ther. 2018;17:1000\u20138.","journal-title":"Integr Cancer Ther"},{"key":"3901_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41574-018-0123-0","volume":"15","author":"JM Argil\u00e9s","year":"2019","unstructured":"Argil\u00e9s JM, Stemmler B, L\u00f3pez-Soriano FJ, Busquets S. Inter-tissue communication in cancer cachexia. Nat Rev Endocrinol. 2019;15:9\u201320.","journal-title":"Nat Rev Endocrinol"},{"key":"3901_CR13","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang T-H, et al. The immune landscape of cancer. Immunity. 2018;48:812-830.e14.","journal-title":"Immunity"},{"key":"3901_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2018.202","volume":"5","author":"S Bakr","year":"2018","unstructured":"Bakr S, Gevaert O, Echegaray S, Ayers K, Zhou M, Shafiq M, et al. A radiogenomic dataset of non-small cell lung cancer. Sci Data. 2018;5: 180202.","journal-title":"Sci Data"},{"key":"3901_CR15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1148\/radiol.12111607","volume":"264","author":"O Gevaert","year":"2012","unstructured":"Gevaert O, Xu J, Hoang CD, Leung AN, Xu Y, Quon A, et al. Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data\u2014methods and preliminary results. Radiology. 2012;264:387\u201396.","journal-title":"Radiology"},{"key":"3901_CR16","doi-asserted-by":"publisher","first-page":"7866","DOI":"10.1038\/ncomms8866","volume":"6","author":"JA Ramilowski","year":"2015","unstructured":"Ramilowski JA, Goldberg T, Harshbarger J, Kloppmann E, Lizio M, Satagopam VP, et al. A draft network of ligand\u2013receptor-mediated multicellular signalling in human. Nat Commun. 2015;6:7866.","journal-title":"Nat Commun"},{"key":"3901_CR17","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1038\/s41467-019-11867-6","volume":"10","author":"M Kim","year":"2019","unstructured":"Kim M, Mun H, Sung CO, Cho EJ, Jeon H-J, Chun S-M, et al. Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening. Nat Commun. 2019;10:3991.","journal-title":"Nat Commun"},{"key":"3901_CR18","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37:773\u201382.","journal-title":"Nat Biotechnol"},{"key":"3901_CR19","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41591-018-0045-3","volume":"24","author":"X Guo","year":"2018","unstructured":"Guo X, Zhang Y, Zheng L, Zheng C, Song J, Zhang Q, et al. Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing. Nat Med. 2018;24:978\u201385.","journal-title":"Nat Med"},{"key":"3901_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.820673","volume":"13","author":"R Zhao","year":"2022","unstructured":"Zhao R, Pan Z, Li B, Zhao S, Zhang S, Qi Y, et al. Comprehensive analysis of the tumor immune microenvironment landscape in glioblastoma reveals tumor heterogeneity and implications for prognosis and immunotherapy. Front Immunol. 2022;13: 820673.","journal-title":"Front Immunol"},{"key":"3901_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017819","volume":"6","author":"J Cui","year":"2011","unstructured":"Cui J, Li F, Wang G, Fang X, Puett JD, Xu Y. Gene-expression signatures can distinguish gastric cancer grades and stages. PLoS ONE. 2011;6: e17819.","journal-title":"PLoS ONE"},{"key":"3901_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/ftox.2022.893050","volume":"4","author":"LL Lecante","year":"2022","unstructured":"Lecante LL, Gaye B, Delbes G. Impact of in utero rat exposure to 17Alpha-ethinylestradiol or genistein on testicular development and germ cell gene expression. Front Toxicol. 2022;4: 893050.","journal-title":"Front Toxicol"},{"key":"3901_CR23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12904-019-0429-2","volume":"18","author":"OM Vagnildhaug","year":"2019","unstructured":"Vagnildhaug OM, Brunelli C, Hjermstad MJ, Strasser F, Baracos V, Wilcock A, et al. A prospective study examining cachexia predictors in patients with incurable cancer. BMC Palliat Care. 2019;18:46.","journal-title":"BMC Palliat Care"},{"key":"3901_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkz016","volume":"3","author":"JWG Derksen","year":"2019","unstructured":"Derksen JWG, Kurk SA, Oskam MJ, Peeters PHM, Punt CJA, Koopman M, et al. Factors contributing to cancer-related muscle wasting during first-line systemic treatment for metastatic colorectal cancer. JNCI Cancer Spectr. 2019;3: pkz014.","journal-title":"JNCI Cancer Spectr."},{"key":"3901_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3390\/cancers12020329","volume":"12","author":"PW Underwood","year":"2020","unstructured":"Underwood PW, Zhang DY, Cameron ME, Gerber MH, Delitto D, Maduka MU, et al. Nicotine induces IL-8 secretion from pancreatic cancer stroma and worsens cancer-induced cachexia. Cancers. 2020;12:329.","journal-title":"Cancers"},{"key":"3901_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s12254-020-00637-6","author":"M Marhold","year":"2020","unstructured":"Marhold M, Topakian T, Unseld M. Sarcopenia in cancer\u2014a focus on elderly cancer patients. Memo - Mag Eur Med Oncol. 2020. https:\/\/doi.org\/10.1007\/s12254-020-00637-6.","journal-title":"Memo - Mag Eur Med Oncol."},{"key":"3901_CR27","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1002\/cam4.841","volume":"5","author":"M Shiono","year":"2016","unstructured":"Shiono M, Huang K, Downey RJ, Consul N, Villanueva N, Beck K, et al. An analysis of the relationship between metastases and cachexia in lung cancer patients. Cancer Med. 2016;5:2641\u20138.","journal-title":"Cancer Med"},{"key":"3901_CR28","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1177\/1758834017719829","volume":"9","author":"P Garrido","year":"2017","unstructured":"Garrido P, Olmedo ME, G\u00f3mez A, Paz Ares L, L\u00f3pez-R\u00edos F, Rosa-Rosa JM, et al. Treating KRAS-mutant NSCLC: latest evidence and clinical consequences. Ther Adv Med Oncol. 2017;9:589\u201397.","journal-title":"Ther Adv Med Oncol"},{"key":"3901_CR29","first-page":"88","volume":"71","author":"E Armingol","year":"2020","unstructured":"Armingol E, Officer A, Harismendy O, Lewis NE. Deciphering cell\u2013cell interactions and communication from gene expression. Nat Rev Genet. 2020;71:88.","journal-title":"Nat Rev Genet"},{"key":"3901_CR30","doi-asserted-by":"publisher","first-page":"19976","DOI":"10.1074\/jbc.M115.638411","volume":"290","author":"DN Seto","year":"2015","unstructured":"Seto DN, Kandarian SC, Jackman RW. A key role for leukemia inhibitory factor in C26 cancer cachexia. J Biol Chem. 2015;290:19976\u201386.","journal-title":"J Biol Chem"},{"key":"3901_CR31","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/rco2.30","volume":"4","author":"Z Cao","year":"2021","unstructured":"Cao Z, Scott AM, Hoogenraad NJ, Osellame LD. Mediators and clinical treatment for cancer cachexia: a systematic review. JCSM Rapid Commun. 2021;4:166\u201386.","journal-title":"JCSM Rapid Commun"},{"key":"3901_CR32","first-page":"2404","volume":"61","author":"A Kadambi","year":"2001","unstructured":"Kadambi A, Mouta Carreira C, Yun CO, Padera TP, Dolmans DE, Carmeliet P, et al. Vascular endothelial growth factor (VEGF)-C differentially affects tumor vascular function and leukocyte recruitment: role of VEGF-receptor 2 and host VEGF-A. Cancer Res. 2001;61:2404\u20138.","journal-title":"Cancer Res"},{"key":"3901_CR33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/ijms19010089","volume":"19","author":"M Mojic","year":"2017","unstructured":"Mojic M, Takeda K, Hayakawa Y. The dark side of IFN-\u03b3: its role in promoting cancer immunoevasion. Int J Mol Sci. 2017;19:89.","journal-title":"Int J Mol Sci"},{"key":"3901_CR34","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/cmi.2010.28","volume":"7","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Huang S, Gong D, Qin Y, Shen Q. Programmed death-1 upregulation is correlated with dysfunction of tumor-infiltrating CD8+ T lymphocytes in human non-small cell lung cancer. Cell Mol Immunol. 2010;7:389\u201395.","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"3901_CR35","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","volume":"124","author":"H Raskov","year":"2020","unstructured":"Raskov H, Orhan A, Christensen JP, G\u00f6genur I. Cytotoxic CD8+ T cells in cancer and cancer immunotherapy. Br J Cancer. 2020;124(2):359\u201367.","journal-title":"Br J Cancer"},{"key":"3901_CR36","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41590-019-0397-y","volume":"20","author":"H Baazim","year":"2019","unstructured":"Baazim H, Schweiger M, Moschinger M, Xu H, Scherer T, Popa A, et al. CD8+ T cells induce cachexia during chronic viral infection. Nat Immunol. 2019;20:701\u201310.","journal-title":"Nat Immunol"},{"key":"3901_CR37","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nature22367","volume":"545","author":"M Philip","year":"2017","unstructured":"Philip M, Fairchild L, Sun L, Horste EL, Camara S, Shakiba M, et al. Chromatin states define tumour-specific T cell dysfunction and reprogramming. Nature. 2017;545:452\u20136.","journal-title":"Nature"},{"key":"3901_CR38","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3390\/cancers11111619","volume":"11","author":"P Bonomi","year":"2019","unstructured":"Bonomi P, Fidler MJ, Shah P, Borgia J. Theoretical and practical implications of treating cachexia in advanced lung cancer patients. Cancers. 2019;11:1619.","journal-title":"Cancers"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-03901-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-03901-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-03901-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T11:15:08Z","timestamp":1676286908000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-03901-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,11]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3901"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-03901-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,11]]},"assertion":[{"value":"22 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human studies have been performed in accordance with the national laws and ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. The study has been performed in accordance with the national laws and ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. The use of computed tomographies from 36 primary NSCLC patients from the Faculty of Medicine, S\u00e3o Paulo State University (UNESP) - Botucatu, Brazil (2012\u20132019) was approved by the Faculty of Medicine Research Ethics Committee (REB#45723921.0.0000.5411). All patients gave their informed consent prior to being included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"116"}}